Onyx Pharmaceuticals, Inc.
83
Plan:
Onyx Pharmaceuticals, Inc. 401k Plan
11
75
88
0
10
20
30
40
50
60
70
80
90
100
For the average 401k participant, the 5 point difference between this plan's BrightScope Rating (83) and the top rated plan (88) could equate to:
[How is this calculated?]
[How is this calculated?]
3 additional years of work Up to $46,700 in lost retirement savings.The delay in retirement calculations apply solely to this defined contribution plan and do not take into account other retirement plans and programs offered by this employer.
Retirement Plan Description
Onyx Pharmaceuticals, Inc. 401k Plan is a defined contribution plan with a profit-sharing component and 401k feature. This plan has a BrightScope Rating of 83, placing it in the top 15% of all plans in its peer group. This plan is also in the top 15% of plans for Salary Deferral. Onyx Pharmaceuticals, Inc. 401k Plan currently has over 400 active participants and over $18.8M in plan assets.
Retirement Plan Details
| Address |
249 East Grand Avenue
South San Francisco, CA 94080 |
| Industry | Manufacturing |
| Administrator | Angela Barbary |
| Sponsor | Matthew Fust |
| Net Plan Assets | $18,800,000 |
| Total Participants | 410 |
| Avg Account Balance | $46,000 |
Compare Other Companies in Peer Group
| The Medicines Company | 82.2 |
| Phadia US | 81.4 |
| Braintree Laboratories | 79.4 |
| Eurand | 75.6 |
| C.B. Fleet Company | 72.1 |
| Novartis | 69.3 |
Comments